Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth- muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I

Molecular Biology of the Cell

Volumn 9, Issue 9, 1998, Pages 2383-2392

  Parker, Alex ^a   Rees, Catherine ^a   Clarke, Jane ^a   Busby Jr , Walker H ^a   Clemmons, David R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MUTANT PROTEIN; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C;

ANIMAL CELL; AORTA; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DNA SYNTHESIS; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; SWINE;

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 0031692870     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.9.9.2383     Document Type: Article

References (33)

1. Arai, A., Busby, W.H., and Clemmons, D.R. (1996a). Binding of insulin-like growth factor I or II to IGF binding protein 2 enables it to bind to heparin or extracellular matrix. Endocrinology 137, 4571-4575.
2. Arai, T., Clarke, J., Parker, A., Busby, W.H., and Clemmons, D.R. (1996b). Effect of substitution of specific amino acids in insulin-like growth factor binding protein-5 on heparin binding and its change in affinity for IGF-I in response to heparin. J. Biol. Chem. 271, 6099-6106.
3. Blat, C., Villaudy, J., and Binoux, M. (1994). In vivo proteolysis of serum insulin-like growth factor binding protein-3 results in minimal availability of IGF to target cells. J. Clin. Invest. 93, 2286-2290.
4. Borstein, P., and Sage, E.H. (1994). Thrombospondins. Methods Enzymol. 245, 62-85.
5. Camacho-Hubner, C., Busby, W.H., McCusker, R.H., Wright, G., and Clemmons, D.R. (1992). Identification of the forms of insulin-like growth factor binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. J. Biol. Chem. 267, 11949-11956.
6. Cardin, A.D., and Weintraub, H.J.R. (1989). Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9, 21-32.
7. Clemmons, D.R., and Gardner, L.I. (1990). A factor contained in plasma is required for IGF binding protein-1 to potentiate the effect of IGF-I on smooth muscle cell DNA synthesis. J. Cell Physiol. 145, 129-135.
8. Clemmons, D.R., and Van Wyk, J.J. (1985). Evidence for a functional role of endogenously produced somatomedin-like peptides in the regulation of DNA synthesis in cultured human fibroblasts and porcine smooth muscle cells. J. Clin. Invest. 75, 1914-1918.
9. Dong, Y., Skoulteki, A., and Pollard, J. (1993). Efficient DNA transfection of quiescent mammalian cells. Nucleic Acids Res. 21, 171-1772.
10. Duan, C., Hawes, S., Prevette, T., and Clemmons, D.R. (1996). Insulin-like growth factor-I (IGF-I) stimulates IGF binding protein-5 synthesis through transcriptional activation of the gene in aortic smooth muscle cells. J. Biol. Chem. 271, 4280-4288.
11. Feige, J.J., and Baird, A. (1995). Crinopexy: extracellular regulation of growth factor action. Kidney Int. 49, s15-s18.
12. Giachelli, C.M., Bae, N., Almeida, M., Denhardt, D.T., Alpers, C.E., and Schwartz, S.M. (1993). Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J. Clin. Invest. 92, 1686-1696.
13. Gitay-Goren, H., Soker, S., Vlodavsky, I., and Nuefeld, G. (1992). The binding of vascular endothelial cell growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J. Biol. Chem. 267, 6093-6098.
14. Gordon, M.Y., Riley, G.P., Watt, S.M., and Graves, M.F. (1987). Compartmentalization of hematopoetic growth factor (GMCSF) by glycosaminoglycans in bone marrow microenvironment. Nature 326, 403-405.
15. Guidice, L.C., Farrell, E.M., Pham, H., Lamson, F.G., and Rosenfeld, R.G. (1990). Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium. J. Clin. Endocrinol Metab. 71, 806-816.
16. Hossenlopp, P., Seurin, D., Segovia-Quinson, B., Hardouin, S., and Binoux, M. (1986). Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal. Biochem. 154, 138-143.
17. Imai, Y., Busby, W.H., Smith, C.E., Clark, J.B., Horvitz, G.D., Rees, C., and Clemmons, D.R. (1997). Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture. J. Clin. Invest. 100, 2596-2605.
18. Jones, J.I., and Clemmons, D.R. (1995). Insulin like growth factor and their binding proteins: biologic actions. Endocr. Rev. 16, 3-34.
19. Jones, J.I., Gockerman, A., Busby, W.H., Camacho-Hubner, C., and Clemmons, D.R. (1993a). Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J. Cell Biol. 121, 679-687.
20. Jones, J.I., Gockerman, A., Busby, W.H., Wright, G., and Clemmons, D.R. (1993b). Insulin-like growth factor binding protein-1 stimulates cell migration and binds to the α5β1 integrin by means of its Arg-Gly-Asp sequence. Proc. Natl. Acad. Sci. USA 90, 10553-10557.
21. Kingston, R. E. (1994). Introduction of DNA into mammalian cells. In: Current Protocols in Molecular Biology, ed. F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl, New York: Wiley-Interscience, 9.1.1-9.1.4.
22. Lopez, C.F., Wrena, J.L., and Massague, J. (1993). Betaglycan presents ligand to TGF-B signalling receptor. Cell 73, 1345-1444.
23. r insulin-like growth factor/somatomedin (IGF) binding protein in fetal porcine and plasma sera. Endocrinology 122, 1-2079.
24. Nam, T.J., Busby, W.H., and Clemmons, D.R. (1994). Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor binding protein-5. Endocrinology 135, 1385-1391.
25. Nam, T.J., Busby, W.H., and Clemmons, D.R. (1997). Insulin-like growth factor binding protein-5 bound to plasminogen activator inhibitor I. Endocrinology 138, 2972-2998.
26. Parker, A., Busby, W.H., and Clemmons, D.R. (1996). Identification of the extracellular matrix binding site for insulin-like growth factor binding protein-5. J. Biol. Chem. 271, 13523-13529.
27. Parker, A., Gockerman, A., Busby, W.H., and Clemmons, D.R. (1995). Properties of an insulin-like growth factor binding protein-4 protease that is secreted by smooth muscle cells. Endocrinology 135, 2470-2476.
28. Pratt, C.W., Whinna, H.C., and Church, F.C. (1992). A comparison of three heparin-binding serine proteinase inhibitors. J. Biol. Chem. 267, 8795-8801.
29. Rechler, M.M. (1993). Insulin like growth factor binding proteins. Vitam. Horm. 47, 1-114.
30. Roberts, R., Gallaher, J., Spooncer, E., Allen, T.D., Bloofield, F., and Dexter, T.M. (1988). Heparan sulfate bound growth factors: a mechanism or stromal cell mediated hematoapoesis. Nature 332, 376-378.
31. Ross, R. (1971). The smooth muscle cell: growth of smooth muscle in cultures and formation of elastic fibers. J. Cell Biol. 50, 172-186.
32. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Sequencing by the Sanger dideoxy-mediated chain termination method. In: Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 13.42-13.53.
33. Yayon, A., Klagsbrun, M., Esko, J.D., Leder, P., and Ornitz, D.M. (1991). Cell surface heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841-848.